Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dalmau

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|January 27, 2007
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patientsEsteban Martínez, Juan A Arnaiz, Daniel Podzamczer, et al.
AIDS (London, England)|August 17, 2005
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavirAnna Ochoa de Echagüen, Mireia Arnedo, Mariona Xercavins, et al.
Journal of the American Chemical Society|April 7, 2025
Investigating Reactivity and Selectivity in a Palladium-Catalyzed Heteroleptic Ligand System for Electrophilic Arene FluorinationShubham Deolka, Mohammad H Samha, Aleria Garcia Roca, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2024
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeksInés Suárez-García, Belén Alejos, Cristina Moreno, et al.
Addiction (Abingdon, England)|February 19, 2016
Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortalityInés Suárez-García, Paz Sobrino-Vegas, David Dalmau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2022
Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral TherapyJuan Berenguer, Inmaculada Jarrín, José M Bellón, et al.
Journal of the American Heart Association|July 31, 2013
HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generationJason V Baker, Kathleen Brummel-Ziedins, Jacqueline Neuhaus, et al.
Antiviral Research|October 2, 2010
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressureFrancisco M Codoñer, Christian Pou, Alexander Thielen, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|June 19, 2018
HIV pre-exposure prophylaxis (PrEP) in Spain: political and administrative situationLuis Miguel García, Carlos Iniesta, Jorge Garrido, et al.
Plos One|November 28, 2012
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, KenyaCecilia Ferreyra, Oliver Yun, Nell Eisenberg, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|January 27, 2007
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patientsEsteban Martínez, Juan A Arnaiz, Daniel Podzamczer, et al.
AIDS (London, England)|August 17, 2005
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavirAnna Ochoa de Echagüen, Mireia Arnedo, Mariona Xercavins, et al.
Journal of the American Chemical Society|April 7, 2025
Investigating Reactivity and Selectivity in a Palladium-Catalyzed Heteroleptic Ligand System for Electrophilic Arene FluorinationShubham Deolka, Mohammad H Samha, Aleria Garcia Roca, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2024
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeksInés Suárez-García, Belén Alejos, Cristina Moreno, et al.
Addiction (Abingdon, England)|February 19, 2016
Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortalityInés Suárez-García, Paz Sobrino-Vegas, David Dalmau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2022
Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral TherapyJuan Berenguer, Inmaculada Jarrín, José M Bellón, et al.
Journal of the American Heart Association|July 31, 2013
HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generationJason V Baker, Kathleen Brummel-Ziedins, Jacqueline Neuhaus, et al.
Antiviral Research|October 2, 2010
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressureFrancisco M Codoñer, Christian Pou, Alexander Thielen, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|June 19, 2018
HIV pre-exposure prophylaxis (PrEP) in Spain: political and administrative situationLuis Miguel García, Carlos Iniesta, Jorge Garrido, et al.
Plos One|November 28, 2012
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, KenyaCecilia Ferreyra, Oliver Yun, Nell Eisenberg, et al.
Pageof 8